US Patent 11116816 Therapeutic vitamin d conjugates
Patent 11116816 was granted and assigned to Extend Biosciences on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+451 characters)
Article
Patent abstract
The invention provides a parathyroid hormone (PTH) compound comprising a PTH peptide. The PTH compound has a significantly increased bioavailability or circulating half-life when compared to a bioavailability or a circulating half-life of a native form of the PTH peptide. The PTH compound has a significantly greater serum concentration at multiple timepoints post-administration to a rat when compared to that of a native PTH peptide.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Christopher So0
Daniel B. Hall0
Howard P. Sard0
Laura M. Hales0
Tarik Soliman0
Vishnumurthy Hegde0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11116816 Therapeutic vitamin d conjugates
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11116816
Date of patent
September 14, 2021
Patent application number
20190129
Date Filed
January 29, 2019
Find more entities like US Patent 11116816 Therapeutic vitamin d conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
